CAS Medical Systems, Inc. Announces New Clinical Study Results Demonstrating Greater Utility of FORE-SIGHT Absolute Cerebral Oximetry Technology

BRANFORD, Conn., June 8, 2009 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that five studies were presented at Euroanaesthesia 2009, the annual meeting of the European Society of Anaesthesia, on June 6-8, 2009 in Milan, Italy, demonstrating utility of the FORE-SIGHT(r) Absolute Cerebral Oximetry technology in monitoring during surgery and critical care. These studies were all conducted by Cathy S. DeDeyne, MD and her colleagues at the Department of Anaesthesia & Neurosurgery, Ziekenhuis Oost-Limburg, Genk, Belgium.

MORE ON THIS TOPIC